A Specific Method for the Measurement of Tacrolimus in Human Whole Blood by Liquid Chromatography/Tandem Mass Spectrometry

Authors:
  • JSJanice Simpson
    Janice Simpson
  • HAHoda I. Aboleneen
    Hoda I. Aboleneen

Abstract
Tacrolimus (FK 506) measurement by immunoassays in clinical samples of organ transplant patients often lacks a specific reference method. A method combining liquid chromatography (LC) with tandem mass spectrometry (MS/MS) was developed to quantify tacrolimus in whole blood. Liquid-liquid extraction was performed on 1 ml of sample before narrow-bore LC/MS/MS analysis. Ascomycin was used as an internal standard. The standard curve was composed of seven points ranging from 1 to 50 µg/l (average r 2 = 0.9999). Limits of detection and quantitation were 0.25 and 0.75 µg/l, respectively. Imprecision was <5% across the therapeutic range. Tacrolimus recovery averaged 62%. The most abundant metabolites detected in clinical samples were 13-O- and 15-O- demethyl tacrolimus. This method was used in a comparison study with a microparticle enzyme immunoassay (MEIA): MEIA = 1.03 LC/MS/MS - 0.084 (µg/l), (Sy/x = 1.43), r 2 = 0.933. With its high sensitivity and specificity, this LC/MS/MS method presents a good reference method for immunoassay evaluation as well as a valuable tool for metabolism studies.

This publication has 17 references indexed in Scilit: